Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Biomerieux Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (72)
Cancellation by sponsor (31)
COVID-19 test kit (4)

Date

2023 (6)
2022 (3)
2021 (6)
2020 (17)
2019 (5)
2018 (10)
2017 (9)
2016 (6)
2015 (8)
2014 (10)
2013 (11)
2012 (10)
2011 (3)
2009 (1)
2008 (1)
2007 (1)

Results for "[search-keyword]"

Search

Sponsor content

107 result(s) found, displaying 21 to 30

Biomerieux Australia Pty Ltd - Enteroviruses 68-71 IVDs (332661)

27 March 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Enteroviruses 68-71 IVDs.
Biomerieux Australia Pty Ltd - Multiple infectious organism IVDs Cancelled under Section 41GL(d) of the Act

16 September 2021

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
Biomerieux Australia Pty Ltd - Human herpes virus 6 IVDs (330800)

4 March 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Human herpes virus 6 IVDs.
Biomerieux Australia Pty Ltd - Adaptor, blood collecting tube, single use (320407)

18 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Adaptor, blood collecting tube, single use.
Biomerieux Australia Pty Ltd - Software IVDs (314912)

28 February 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biomerieux Australia Pty Ltd - Software IVDs.
Biomerieux Australia Pty Ltd - Bacterial infectious disease IVDs Cancelled under Section 41GL(d) of the Act

1 September 2020

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
Biomerieux Australia Pty Ltd - Clinical chemistry biological screening IVDs Cancelled under Section 41GL(d) of the Act

18 August 2020

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
Biomerieux Australia Pty Ltd - Influenza virus IVDs Cancelled under Section 41GL(d) of the Act

18 August 2020

Cancellation by sponsor

Requested by Biomerieux Australia Pty Ltd
SARS-COV-2 R-GENE®

3 August 2020

COVID-19 test kit

Nucleic Acid Test - Intended for use: Laboratory.
VIDAS® SARS-COV-2 IgM

3 August 2020

COVID-19 test kit

Immunoassay - Intended for use: Laboratory.

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.